Boston Scientific Corp. (BSX)

Finanzdaten der Boston Scientific Corp.-Aktie (BSX)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	3.52% 3,856.00	3,725.00	3,527.00	3,599.00	3,389.00
Cost Of Revenue	5.41% 1,209.00	1,147.00	1,101.00	1,058.00	1,040.00
Gross Profit	2.68% 2,648.00	2,579.00	2,426.00	2,542.00	2,349.00
Operating Expenses	1.10% 1,973.00	1,995.00	1,733.00	2,028.00	1,797.00
Interest Income/Expense	6.15% 69.00	65.00	66.00	70.00	65.00
Benefits Costs and Expenses	0.87% 3,248.00	3,220.00	2,917.00	3,173.00	2,945.00
Costs And Expenses	0.87% 3,248.00	3,220.00	2,917.00	3,173.00	2,945.00
Operating Income/Loss	15.58% 675.00	584.00	693.00	514.00	552.00
Nonoperating Income/Loss	15.19% -67.00	-79.00	-83.00	-88.00	-108.00
Income/Loss From Continuing Operations Before Tax	20.40% 608.00	505.00	610.00	426.00	444.00
Income Tax Expense/Benefit	11,400% 115.00	1.00	105.00	156.00	131.00
Income/Loss From Continuing Operations After Tax	2.18% 493.00	504.00	505.00	270.00	313.00
Net Income/Loss	2.18% 493.00	504.00	504.00	270.00	314.00
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	104.55% 1.00	-22.00	-1.00	-	-
Basic Average Shares	34,862% 1,468.40	4.20	1,464.50	1,446.20	1,435.80
Diluted Average Shares	33,575% 1,481.70	4.40	1,475.00	1,456.20	1,446.00
Basic Earnings Per Share	0.00% 0.34	0.34	0.34	0.18	0.21
Diluted Earnings Per Share	2.94% 0.33	0.34	0.34	0.18	0.21
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-